APA (7th ed.) Citation

Kennedy, R., Macrohon, C. R. L., David, M. L. G. V., Lee, M., Salama, A. K. S., & Shariff, A. (2025). Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy. JCEM Case Reports, 3(3), 1. https://doi.org/10.1210/jcemcr/luaf023

Chicago Style (17th ed.) Citation

Kennedy, Randol, Calvin Rei L. Macrohon, Mary Lourdes Grace V. David, Meg Lee, April K S. Salama, and Afreen Shariff. "Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy." JCEM Case Reports 3, no. 3 (2025): 1. https://doi.org/10.1210/jcemcr/luaf023.

MLA (9th ed.) Citation

Kennedy, Randol, et al. "Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy." JCEM Case Reports, vol. 3, no. 3, 2025, p. 1, https://doi.org/10.1210/jcemcr/luaf023.